Abemaciclib
CDK 4/6 inhibitor
Verzenio
78 trials
Indicated for 1 condition
CDK 4/6 inhibitor
Verzenio
78 trials
Indicated for 1 condition
CYP17A1 inhibitor
Zytiga
0 trials
Indicated for 1 condition
Enzyme replacement
Replagal
5 trials
Indicated for 1 condition
Anti-CD52 antibody
Lemtrada
52 trials
Indicated for 2 conditions
Immunosupressant
Litak, Mavenclad, Leustatin
33 trials
Indicated for 2 conditions
MEK inhibitor
Cotellic
25 trials
Indicated for 1 condition
Anti-CD38 antibody
Darzalex
0 trials
Indicated for 1 condition
Immunomodulatory agent
Tecfidera
51 trials
Indicated for 1 condition
CFTR modulator
Trikafta, Kaftrio
0 trials
Indicated for 1 condition
Bispecific monoclonal antibody
Hemlibra
17 trials
Indicated for 1 condition
S1PR modulators
Gilenya
19 trials
Indicated for 1 condition
Selective estrogen receptor degrader
Faslodex
0 trials
Indicated for 1 condition
Immunomodulatory agent
Copolymer 1
Copaxone
0 trials
Indicated for 1 condition
Enzyme replacement
Cerezyme
14 trials
Indicated for 1 condition
Anti-HER2 TKI
Tykerb, Tyverb
0 trials
Indicated for 1 condition
Bcr-Abl TKI
Tasigna
52 trials
Indicated for 1 condition
CDK 4/6 inhibitor
Ibrance
0 trials
Indicated for 1 condition
CDK 4/6 inhibitor
Kisqali
53 trials
Indicated for 1 condition
Glutamate modulator
Rilutek
0 trials
Indicated for 1 condition
Anti-HER2 antibody-drug conjugate
Kadcyla
54 trials
Indicated for 1 condition